Now as the roles of OPN in NASH‐HCC development are established, further research will focus on molecular mechanism of OPN action in early vs. late stages of this devastating disease in order to elucidate potential strategies for its prevention or treatment. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatohepatitis.